May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Change of Nerve Growth Factor Level in Serum and Tear Between Control and Diabetic Retinopathy Patients and Its Clinical Impact
Author Affiliations & Notes
  • H. Lee
    Ophthalmology, Yonsei, Seoul, Republic of Korea
  • K.–S. Park
    Ophthalmology, Yonsei, Seoul, Republic of Korea
  • G. Seong
    Ophthalmology, Yonsei, Seoul, Republic of Korea
  • E. Kim
    Ophthalmology, Yonsei, Seoul, Republic of Korea
  • J. Kim
    Ophthalmology, Chung–Ang University Yong–San Hospital, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships  H. Lee, None; K. Park, None; G. Seong, None; E. Kim, None; J. Kim, None.
  • Footnotes
    Support  KRF–2005–003–E00174
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 953. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Lee, K.–S. Park, G. Seong, E. Kim, J. Kim; Change of Nerve Growth Factor Level in Serum and Tear Between Control and Diabetic Retinopathy Patients and Its Clinical Impact . Invest. Ophthalmol. Vis. Sci. 2006;47(13):953.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare the Nerve growth factor (NGF) level in serum and ocular surface between control and diabetic retinopathy patients. We also tried to determine the role of neurotrophic factors in progression of diabetic retinopathy.

Methods: : Twenty–three age and sex matched control, 40 non proliferative diabetic retinopathy (NPDR), and 29 proliferative diabetic retinopathy (PDR) patients were included. General physical examination was performed and blood sugar, HbA1C, renal and lipid profile of serum were determined. Serum and tear concentration of NGF were also determined with ELISA. Also, the correlations between the severity of the diabetes and concentration of NGF were evaluated.

Results: : The serum concentration of NGF was 39.1±12.0 ng/ml in control, 45.2±11.2 ng/ml in NPDR patients and 95.1±18.6 ng/ml in PDR patients (p<0.001, ANOVA). The tear concentration of NGF was 1.2±1.1 ng/ml in control, 1.7±0.1 ng/ml in NPDR and 17.3±5.2 ng/ml in PDR (p<0.001, ANOVA). Serum and tear NGF level had statistically significant correlation with each other (r=0.713, p=0.002; pearson correlation coefficient). And the tear and serum concentration of NGF correlated well with severity of diabetic retinopathy, uncorrected visual acuity, insulin dose, HbA1C, and fasting blood sugar level in diabetic retinopathy patients.

Conclusions: : Tear and serum NGF concentration was significantly elevated in PDR patients. Considering the significant correlation of the tear and serum NGF level with the progression of diabetic retinopathy, the tear and serum NGF would be considered as a candidate for a new marker of diabetic retinopathy progression.

Keywords: diabetes • cytokines/chemokines • cornea: tears/tear film/dry eye 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×